A Multisite Randomized Clinical Trial to Examine the Efficacy and Mechanisms of Immersive Virtual Walking Treatment for Neuropathic Pain in Spinal Cord Injury
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Spinal Cord Injuries
- Sponsor
- Texas A&M University
- Enrollment
- 250
- Locations
- 3
- Primary Endpoint
- Change in Pain Intensity
- Status
- Recruiting
- Last Updated
- 4 months ago
Overview
Brief Summary
The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.
Detailed Description
Many people with SCI experience neuropathic pain. Neuropathic pain is often described as sharp, burning, or electric. 'Traditional' treatments often do not do a good job of reducing neuropathic pain. Therefore, it is important to see if 'non-traditional' treatments might work. Scientists think that neuropathic pain occurs in SCI because the sensations coming from the eyes and up the spinal cord to the brain do not match what the brain thinks it told the body to do. This 'mis-match' may result in changes in the brain that make neuropathic pain possible. Virtual reality walking reduces this 'mis-match.' It does this by creating the 'illusion' that the person is walking. The brain then thinks it is telling the body to walk AND the information coming from the eyes matches its instructions. This 'matching' may reverse the brain changes that made neuropathic pain possible. The current study is specifically focused on individuals whose SCI has been classified as complete (ASIA A).
Investigators
Eligibility Criteria
Inclusion Criteria
- •The study will recruit individuals with complete injury (American Spinal Injury Association \[ASIA\] classification A) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury. Additional criteria will include:
- •Must have persistent NP symptoms that are of daily severity of at least 4/10 for 3 or more months
- •Must endorse more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI
- •Must be 18 years of age or older
- •Must be more than one year post-injury to begin study (can be screened at an earlier time for eligibility)
- •Must have mobile connectivity with usable service
- •Must be stable on pain medication for 1 or more months
- •Must be cleared on the VRWalk physical activity clearance scale
- •Must not have motion sickness that interferes with daily life
Exclusion Criteria
- •Individuals with Injury levels between C1 and C4
- •Individuals under the age of 18
- •Individuals who were injured within the past year
- •Individuals who cannot comprehend spoken English
- •Individuals who are in prison
- •Individuals who are blind
- •Individuals who experience severe motion sickness
Outcomes
Primary Outcomes
Change in Pain Intensity
Time Frame: Baseline - final follow up (up to 18 months)
The Numeric Rating Scale (NRS) measures pain intensity via 0-10 numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain imaginable.
Secondary Outcomes
- Post treatment change(at follow up (up to 18 months))
- Change in Pain Interference(Baseline - final follow up (up to 18 months))
- Change in mood(Baseline - final follow up (up to 18 months))
- Change in Pain Quality(Baseline - final follow up (up to 18 months))
- Neurological changes(Baseline - 6 months)
- Change in quality of life(Baseline - final follow up (up to 18 months))